Fennel Oil and Menstrual Cramps: Reading the Trials Honestly

There is a real body of trials on fennel and period pain, and a headline from it that sounds like a win: fennel performed about as well as mefenamic acid. Read the trial tables and the picture changes. The "fennel oil" in most of those trials was swallowed as drops, not applied or inhaled, the trials were small, and the people who pooled them rate the certainty of the result as low. This page walks through what was tested, what was found, and why we do not recommend taking the bottle you buy from us internally. It is one of several pages that grade fennel claims against the same standard; the overview is our benefits evidence review.

Fennel Essential Oil bottle

Fennel Essential Oil

Our own Fennel Essential Oil, in sizes from 0.5 oz to bulk.

From $13.99

Shop Now →

What the volunteers were actually given

The most complete pooled analysis is a 2020 systematic review in Nutrients of 12 randomized trials, all run in Iran (Lee et al., 2020). Nine of the 12 are labelled "oil" in the review's table, and three are capsules of fennel extract. Every one was oral. The review set aside fennel oil used for massage, so no skin or aroma trial is in its numbers.

The oil doses were counted in drops: for example, a 2% preparation at 25 drops every six hours for a month in one trial, and 20 to 30 drops every four to six hours for three months in another. A third gave a single 1% or 2% dose when pain began. The review does not state the volume of a drop, and it does not say in the table whether each "oil" was a steam-distilled essential oil, so drops cannot be converted to milligrams from that source. Only one of the 12 is explicitly called an essential oil, in the title of its reference.

That matters for us. We sell a 100% undiluted oil that we do not describe as fit for internal use, and our guidance is to dilute to 0.5% to 2% in a carrier oil for skin only. A bottle of ours is not the product those volunteers took. For the longer reasoning, see why the bottle is not food.

The numbers, with their limits attached

SourceWhat was comparedResultWhat limits it
Lee et al., 2020 (7 trials, n = 502)Fennel vs drugs (mefenamic acid or ibuprofen)Standardized mean difference 0.07, 95% CI −0.08 to 0.21, I² = 0%Certainty rated low; small trials; all in Iran
Lee et al., 2020 (7 trials, n = 468)Fennel vs placeboSMD −3.27, 95% CI −5.28 to −1.26, I² = 98%; five trials favoured fennel, two did notHeterogeneity of 98% means the trials disagree wildly; asymmetric funnel plot suggests small positive studies are over-represented
EMA assessment report, 2008, describing Jahromi et al., 200330 patients, three cycles: no treatment, mefenamic acid, 2% fennel oil (25 drops every four hours)Both reduced pain against the untreated cycle; mefenamic acid was more activeNot blinded; small; 5 of 30 withdrew because of the odour; one reported a mild increase in menstrual flow
Negi et al., 2026Fennel 480 mg capsules, ginger 500 mg, placebo, 384 young women, three cycles, triple-blind crossoverPain scores fell to 4.61 on fennel and 3.28 on ginger; placebo stayed near 6.24Capsules of fennel, not an essential oil; three sites in one Indian city; authors report ginger outperformed fennel

The sources do not fully agree. The 2020 pooling calls fennel equivalent to drugs; the single older trial in the European regulator's report found the drug more active. Neither is wrong: one is a pooled average of small studies, the other is one small unblinded study. Carry that caution back to every number in the table.

A second review that reads the bias differently

A 2026 systematic review of herbs from the carrot family (anise, dill, cumin and fennel among them) pooled 14 studies for primary dysmenorrhea (Thaliyil Poduval et al., 2026). It found low risk of bias in randomization and outcome measurement for the fennel and anise trials that used a placebo, but concerns about deviations from the intended intervention and selective reporting in the fennel and dill trials that used a standard drug as comparator. It still reported a statistically significant pooled effect against standard treatments, and concluded these herbs are "potentially effective adjunct therapies" while calling for further high-quality trials.

So the two reviews both lean positive and both ask for better trials, but they locate the weakness in different places: Lee and colleagues rate overall certainty as low, while this one flags the drug-comparison trials in particular, which are exactly the ones behind the "as good as mefenamic acid" headline. We have only the abstract of the 2026 review, so treat that comparison as a pointer, not a ruling.

"Equivalent to mefenamic acid" is a weaker claim than it sounds

An equivalence result against a drug only means something if the trial could have detected a difference. Small, unregistered trials with mixed pain scales (the review's table shows visual analogue scales, a verbal scoring system labelled AMVMS, and a Likert scale) often could not. Lee and colleagues report that only six of the 12 trials generated their random sequence adequately, only four described allocation concealment, and most trials were not registered. Only three assessed adverse events at all, so safety cannot be judged from this set. In plain terms: the evidence is suggestive and thin, and it is on a swallowed preparation.

Why the hormone-active chemistry cuts the other way

The European Medicines Agency's 2008 assessment report on fennel records that trans-anethole produced an oestrogen-like effect in rats (80 mg/kg by mouth for three days increased uterine weight in immature females) and in a yeast assay expressing the human oestrogen receptor at high concentrations (EMA, 2008). The same report says that if excessive doses are ingested, this activity may affect hormone therapy, including oral contraception. The report's own verdict on the dysmenorrhoea evidence is that human investigations are "very preliminary", with the plausibility resting on in-vitro smooth-muscle studies.

That is reasoning, not a trial result, but it is why we do not treat "it is natural and it helps cramps" as a complete thought. A compound that acts on hormone receptors in a dish belongs in the same sentence as the people who should avoid it.

Which fennel, which preparation

Three different things have been tested or described, and they are not interchangeable: a dried-fruit tea (the subject of the EMA monograph), capsules of extract (three of the 12 trials), and oral drops of oil (nine of the 12). The 2008 EMA report's description of the Jahromi trial says only "fennel oil obtained by steam distillation of dried fruit"; none of the sources we read says whether sweet or bitter fennel was used. The 2024 monograph covers Foeniculum vulgare subsp. vulgare var. vulgare, which is the bitter type, and its estragole limits are written for that herbal tea. We sell sweet fennel, and we have said elsewhere that advice about "fennel oil" without a variety is incomplete. Carrying a bitter-fennel monograph over to our oil, or a swallowed-oil trial over to a diluted massage oil, would be an extrapolation in both directions.

Who should not use it, and when cramps are not a fennel question

The EMA's 2024 herbal monograph for fennel fruit (a dried-fruit tea, a different product from our oil) says safety in pregnancy and lactation has not been established and that use is not recommended; it lists hypersensitivity to plants of the carrot family, to anethole, or to mugwort pollen as a contraindication (EMA, 2024). Our own published cautions go further for the oil: avoid it in pregnancy and while breastfeeding (see our pregnancy page), and leave it alone with an oestrogen-sensitive condition or epilepsy (see contraindications and interactions).

Pain that changes pattern deserves a clinician more than any oil. The NHS advises a GP appointment when periods become more painful, heavier or irregular, when the pain stops you doing usual activities, or when there is pain during sex or bleeding between periods, and urgent help when pelvic pain is severe or worse than usual and painkillers have not helped (NHS, period pain). The same page lists heat, exercise, tummy and back massage, and ibuprofen or paracetamol as the first things to try. An obstetrician-gynecologist can assess whether something other than ordinary cramps is going on.

What we will and will not say

We will not say our oil relieves cramps: no trial in the set above tested a diluted topical or aroma use of fennel oil, so anything we suggested about abdominal massage would be an extrapolation. We can say what is in the bottle and how it is made, and that we publish estragole and anethole per lot. For period pain, the evidence-backed first steps are the ordinary ones in the NHS list, and a pharmacist or physician is the person to ask about doses.

The wider picture of what fennel research does and does not support is in our benefits evidence review, and the companion piece on menopause and the oestrogen claim uses the same sources.

Fennel Essential Oil bottle

Fennel Essential Oil

Fennel Essential Oil from our own shop, in sizes from 0.5 oz to bulk.

From $13.99

Shop Now →

Sources & Further Reading